Current Funding
Chagnon Family – Brain Canada Multi-Investigator Research Initiative (MIRI)
Title: Prevention of Alzheimer’s Dementia with Cognitive Remediation plus Transcranial Direct Current Stimulation in Mild Cognitive Impairment and Depression (PACT-MD)
Amount: $10,000,000 CAD; Jan 2015 – Jan 2023
Project: PACT-MD

Weston Brain Institute & Alzheimer’s Drug Discovery Foundation Canada
Title: The SARTAN-AD Trial: A Randomized, Open Label, Proof of Concept Study of Telmisartan vs. Perindopril in Hypertensive Mild-Moderate Alzheimer’s Disease Patients
Amount: $1442,388 CAD; 5 years, May 2013-April 2019
Project: SARTAN-AD

Ontario Brain Institute
Title: The Ontario Neurodegenerative Disease Research Initiative
Amount: $28,000,500 CAD; 5 years, 2013-2018
Project: ONDRI

Weston Brain Institute & Brain Canada
Title: The Brain Eye Amyloid Memory (BEAM) Study: Validation of Ocular Measures as Potential Biomarkers for Early Detection of Brain Amyloid and Neurodegeneration
Amount: $1,498,490 CAD; 3 years, Sept 2013-Aug 2016
Project: BEAM

Department of Medicine Innovation Fund – University of Toronto
Title: Development of the Toronto Dementia Research Alliance (TDRA) Database and Creation of an Integrated Discovery System in Neurodegenerative Disorders.
Amount: $75,000 CAD, 1 year, April 2013-March 2014
Project: TDRA-DB

Division of Neurology New Initiative Fund – University of Toronto
Title: Clinical intake forms on tablet, programming of database
Amount: $60,000 CAD, April 2013-March 2014
Project: TDRA-DB

Grant/Funding Application Deadlines
• Canadian Institutes of Health Research – Project Grant : Spring 2018 Priority Announcement (Specific Research Areas). Deadline February 6, 2018. Link
• Canadian Institutes of Health Research – Project Grant : Spring 2018. Deadline February 6, 2018. link


Alzheimer’s Association

Alzheimer Society of Canada


Weston Brain Institute
• Deadline for Alzheimer’s and related disorders: January 2018
• Transformational Research : Canada 2018. Deadline February 2018
• NEW for 2018 – Early Phase Clinical Trials: Canada. Deadline is Rolling
• Rapid Response – Canada 2018 (Alzheimer’s and Related Diseases)
– Letter of Intent Deadline: April 19th, 2018 at 2pm
– Anticipated Award: October 2018
• Rapid Response – Canada 2019 – Parkinson’s and related diseases. Opens June 2018
• Biomarkers against Neurodegenerative Diseases. Opens February 2018

Brain Canada
• Deadline for Letter of Intent for Canadian Parkinson Network and Registry: November 13, 2017